Join us Sept. 24 in NYC to connect with execs from Digitas, Claire's, Marriott, Havas and others
Mushroom boardroom: Why some execs are using psychedelics to get through the workday
This is a preview of a story that was initially published on our sister site, WorkLife, which covers the future of the workplace.
After his father died in 2018, Paul Marlow struggled with fear, anxiety and depression. That’s when he turned to microdosing psychedelics as a remedy — and he hasn’t looked back.
Microdosing, he said, helps him focus at work. As the pandemic persists, many who are looking for a jolt of motivation, inspiration or medication are turning to microdosing — that is, ingesting small amounts of psychedelic drugs to combat mental health issues and enhance creativity, productivity and physical well-being. Read the full story on WorkLife.
More in Marketing
The case for and against retail media networks as brand-building channels
Retail media networks pitch brand-building on shopper data, but ROI metrics, costs and budget fights hold them back.
Pinterest unveils new suite of ad tools, including Visual Search Ads, in its pitch to brands
For brands, Pinterest executives said, the opportunity is huge. Pinterest’s user base is growing and, importantly for many companies, young.
Future of Marketing Briefing: Creators are learning to pitch AEO, not just audiences
The next line in a creator’s pitch: I got cited